Contineum Therapeutics Inc (CTNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 0 | 50,000 |
| Gross Profit | N/A | N/A | 0 | N/A | 50,000 |
| Operating Expenses | 10,944 | 9,930 | 9,676 | 8,069 | 11,063 |
| Operating Income | -10,944 | -9,930 | -9,676 | -8,069 | 38,937 |
| Interest Expense | 0 | 0 | 0 | 0 | 116 |
| Other Income | 1,935 | 1,513 | 1,746 | 1,700 | 3,472 |
| Pre-tax Income | -9,009 | -8,417 | -7,930 | -6,369 | 42,293 |
| Income Tax | N/A | N/A | -161 | -118 | 729 |
| Net Income Continuous | -9,009 | -8,417 | -7,769 | -6,251 | 41,564 |
| Net Income | $-9,009 | $-8,417 | $-7,769 | $-6,251 | $41,564 |
| EPS Basic Total Ops | -0.39 | -3.55 | 3.61 | -2.69 | 2.56 |
| EPS Basic Continuous Ops | -0.39 | -3.55 | -3.49 | -2.69 | 18.13 |
| EPS Diluted Total Ops | -0.39 | -3.55 | 4.05 | -2.69 | 0.84 |
| EPS Diluted Continuous Ops | -0.39 | -3.55 | -0.34 | -2.69 | 11.83 |
| EPS Diluted Before Non-Recurring Items | -0.39 | -3.55 | N/A | N/A | N/A |
| EBITDA(a) | $-10,884 | $-9,869 | $-9,640 | $-8,026 | $38,756 |